Literature DB >> 15147369

Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemia.

Christine J Harrison1, Anthony V Moorman, Zoë J Broadfield, Kan L Cheung, Rachel L Harris, G Reza Jalali, Hazel M Robinson, Kerry E Barber, Sue M Richards, Christopher D Mitchell, Tim O B Eden, Ian M Hann, Frank G H Hill, Sally E Kinsey, Brenda E S Gibson, John Lilleyman, Ajay Vora, Anthony H Goldstone, Ian M Franklin, Jill Durrant, Mary Martineau.   

Abstract

This study of children and adults with acute lymphoblastic leukaemia (ALL) is the largest series of patients with hypodiploidy (<46 chromosomes) yet reported. The incidence of 5% was independent of age. Patients were subdivided by the number of chromosomes; near-haploidy (23-29 chromosomes), low hypodiploidy (33-39 chromosomes) and high hypodiploidy (42-45 chromosomes). The near-haploid and low hypodiploid groups were characterized by their chromosomal gains and a doubled hyperdiploid population. Structural abnormalities were more frequent in the low hypodiploid group. Near-haploidy was restricted to children of median age 7 years (range 2-15) whereas low hypodiploidy occurred in an older group of median age 15 years (range 9-54). Patients with 42-45 chromosomes were characterized by complex karyotypes involving chromosomes 7, 9 and 12. The features shared by the few patients with 42-44 chromosomes and the large number with 45 justified their inclusion in the same group. Survival analysis showed a poor outcome for the near-haploid and low hypodiploid groups compared to those with 42-45 chromosomes. Thus cytogenetics, or at least a clear definition of the modal chromosome number, is essential at diagnosis in order to stratify patients with hypodiploidy into the appropriate risk group for treatment.

Entities:  

Mesh:

Year:  2004        PMID: 15147369     DOI: 10.1111/j.1365-2141.2004.04948.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  52 in total

Review 1.  Genomic profiling of B-progenitor acute lymphoblastic leukemia.

Authors:  Charles G Mullighan
Journal:  Best Pract Res Clin Haematol       Date:  2011-11-06       Impact factor: 3.020

2.  Array-based comparative genomic hybridization detects copy number variations with prognostic relevance in 80% of ALL with normal karyotype or failed chromosome analysis.

Authors:  V Mühlbacher; T Haferlach; W Kern; M Zenger; S Schnittger; C Haferlach
Journal:  Leukemia       Date:  2015-10-09       Impact factor: 11.528

3.  Outcome of children with hypodiploid ALL treated with risk-directed therapy based on MRD levels.

Authors:  Charles G Mullighan; Sima Jeha; Deqing Pei; Debbie Payne-Turner; Elaine Coustan-Smith; Kathryn G Roberts; Esmé Waanders; John K Choi; Xiaotu Ma; Susana C Raimondi; Yiping Fan; Wenjian Yang; Guangchun Song; Jun J Yang; Hiroto Inaba; James R Downing; Wing H Leung; W Paul Bowman; Mary V Relling; William E Evans; Jinghui Zhang; Dario Campana; Ching-Hon Pui
Journal:  Blood       Date:  2015-11-02       Impact factor: 22.113

4.  Masked hypodiploidy: Hypodiploid acute lymphoblastic leukemia (ALL) mimicking hyperdiploid ALL in children: A report from the Children's Oncology Group.

Authors:  Andrew J Carroll; Mary Shago; Fady M Mikhail; Susana C Raimondi; Betsy A Hirsch; Mignon L Loh; Elizabeth A Raetz; Michael J Borowitz; Brent L Wood; Kelly W Maloney; Leonard A Mattano; Eric C Larsen; Julie Gastier-Foster; Eileen Stonerock; Denise Ell; Samir Kahwash; Meenakshi Devidas; Richard C Harvey; I-Ming L Chen; Cheryl L Willman; Stephen P Hunger; Naomi J Winick; William L Carroll; Kathleen W Rao; Nyla A Heerema
Journal:  Cancer Genet       Date:  2019-07-30

5.  TP53 Germline Variations Influence the Predisposition and Prognosis of B-Cell Acute Lymphoblastic Leukemia in Children.

Authors:  Maoxiang Qian; Xueyuan Cao; Meenakshi Devidas; Wenjian Yang; Cheng Cheng; Yunfeng Dai; Andrew Carroll; Nyla A Heerema; Hui Zhang; Takaya Moriyama; Julie M Gastier-Foster; Heng Xu; Elizabeth Raetz; Eric Larsen; Naomi Winick; W Paul Bowman; Paul L Martin; Elaine R Mardis; Robert Fulton; Gerard Zambetti; Michael Borowitz; Brent Wood; Kim E Nichols; William L Carroll; Ching-Hon Pui; Charles G Mullighan; William E Evans; Stephen P Hunger; Mary V Relling; Mignon L Loh; Jun J Yang
Journal:  J Clin Oncol       Date:  2018-01-04       Impact factor: 44.544

6.  Novel gene targets detected by genomic profiling in a consecutive series of 126 adults with acute lymphoblastic leukemia.

Authors:  Setareh Safavi; Markus Hansson; Karin Karlsson; Andrea Biloglav; Bertil Johansson; Kajsa Paulsson
Journal:  Haematologica       Date:  2014-09-26       Impact factor: 9.941

Review 7.  Genomic and pharmacogenetic studies of childhood acute lymphoblastic leukemia.

Authors:  Ching-Hon Pui
Journal:  Front Med       Date:  2014-12-15       Impact factor: 4.592

Review 8.  Redefining ALL classification: toward detecting high-risk ALL and implementing precision medicine.

Authors:  Stephen P Hunger; Charles G Mullighan
Journal:  Blood       Date:  2015-05-21       Impact factor: 22.113

9.  Refractory acute monoblastic leukaemia with low hypodiploidy.

Authors:  Su Han Lum; Tong Foh Chin; Kee Hie Lau; Tsiao Yi Yap; Revathi Rajagopal; Hany Ariffin
Journal:  Int J Hematol       Date:  2014-01-28       Impact factor: 2.490

10.  Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia.

Authors:  James B Nachman; Nyla A Heerema; Harland Sather; Bruce Camitta; Erik Forestier; Christine J Harrison; Nicole Dastugue; Martin Schrappe; Ching-Hon Pui; Giuseppe Basso; Lewis B Silverman; Gritta E Janka-Schaub
Journal:  Blood       Date:  2007-05-01       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.